BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36309358)

  • 41. Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma.
    Reynolds HM; Parameswaran BK; Finnegan ME; Roettger D; Lau E; Kron T; Shaw M; Chander S; Siva S
    PLoS One; 2018; 13(8):e0202387. PubMed ID: 30114235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI.
    Sufana Iancu A; Colin P; Puech P; Villers A; Ouzzane A; Fantoni JC; Leroy X; Lemaitre L
    World J Urol; 2013 Feb; 31(1):13-9. PubMed ID: 22996759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma.
    Bharwani N; Miquel ME; Powles T; Dilks P; Shawyer A; Sahdev A; Wilson PD; Chowdhury S; Berney DM; Rockall AG
    Br J Cancer; 2014 Feb; 110(3):616-24. PubMed ID: 24366299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.
    Notohamiprodjo M; Staehler M; Steiner N; Schwab F; Sourbron SP; Michaely HJ; Helck AD; Reiser MF; Nikolaou K
    Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation.
    Labeur TA; Runge JH; Klompenhouwer EG; Klümpen HJ; Takkenberg RB; van Delden OM
    Abdom Radiol (NY); 2019 Aug; 44(8):2740-2750. PubMed ID: 31069479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
    Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
    AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Biexponential and Monoexponential Model of Diffusion-Weighted Imaging for Distinguishing between Common Renal Cell Carcinoma and Fat Poor Angiomyolipoma.
    Ding Y; Zeng M; Rao S; Chen C; Fu C; Zhou J
    Korean J Radiol; 2016; 17(6):853-863. PubMed ID: 27833401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apparent diffusion coefficient (ADC) measurement in endometrial carcinoma: effect of region of interest methods on ADC values.
    Inoue C; Fujii S; Kaneda S; Fukunaga T; Kaminou T; Kigawa J; Harada T; Ogawa T
    J Magn Reson Imaging; 2014 Jul; 40(1):157-61. PubMed ID: 24677497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.
    Fouladi DF; Zarghampour M; Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Khoshpouri P; Kamel IR
    Eur Radiol; 2020 Jan; 30(1):291-300. PubMed ID: 31209620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
    Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Textural differences in apparent diffusion coefficient between low- and high-stage clear cell renal cell carcinoma.
    Kierans AS; Rusinek H; Lee A; Shaikh MB; Triolo M; Huang WC; Chandarana H
    AJR Am J Roentgenol; 2014 Dec; 203(6):W637-44. PubMed ID: 25415729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PET/CT in brachytherapy early response evaluation of pancreatic ductal adenocarcinoma xenografts: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
    Liu Y; Liu M; Liu X; Zhou Y
    Abdom Radiol (NY); 2019 Mar; 44(3):950-957. PubMed ID: 30315322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Volumetric quantitative histogram analysis using diffusion-weighted magnetic resonance imaging to differentiate HCC from other primary liver cancers.
    Lewis S; Peti S; Hectors SJ; King M; Rosen A; Kamath A; Putra J; Thung S; Taouli B
    Abdom Radiol (NY); 2019 Mar; 44(3):912-922. PubMed ID: 30712136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
    Choi YA; Kim CK; Park SY; Cho SW; Park BK
    AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apparent diffusion coefficient characteristics of various adrenal tumors.
    Hida T; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Fujita N; Shimamoto D; Yokomizo A; Tatsugami K; Inokuchi J; Kubo Y; Honda H
    Magn Reson Med Sci; 2014; 13(3):183-9. PubMed ID: 24990461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High signal renal tumors on DWI: the diagnostic value of morphological characteristics.
    Zhang H; Pan J; Shen Y; Bai X; Wang Y; Wang H; Ye H
    Abdom Radiol (NY); 2019 Jan; 44(1):239-246. PubMed ID: 30141057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudotumours in chronic kidney disease: can diffusion-weighted MRI rule out malignancy.
    Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A
    Eur J Radiol; 2013 Nov; 82(11):1870-6. PubMed ID: 23932396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
    Li X; Zhang K; Shi Y; Wang F; Meng X
    J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.